Who owns CG Oncology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CGON from SEC Form 13F filings across 228 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 228 institutions disclosed 93.8M shares of CG Oncology, Inc. worth $6.66B — about 106.4% of shares outstanding; the largest disclosed holder is RTW INVESTMENTS, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
228
13F holders
$6.66B
value, 2026 filers
106.4%
of shares outstanding (93.8M sh)
34
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CGON's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RTW INVESTMENTS, LP | 8.5M | $605.0M | 5.2% | 9.7% | +21.9% |
| 2 | T. Rowe Price Investment Management, Inc. | 6.6M | $470.1M | 0.3% | 7.5% | -1.5% |
| 3 | Decheng Capital LLC | 6.4M | $452.7M | 61.9% | 7.2% | 0.0% |
| 4 | BlackRock, Inc. | 6.3M | $444.5M | 0.0% | 7.1% | +23.5% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 5.3M | $378.3M | 0.1% | 6% | -0.9% |
| 6 | FMR LLC | 4.2M | $295.7M | 0.0% | 4.7% | +10.5% |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.8M | $270.3M | 0.0% | 4.3% | +4.2% |
| 8 | TCG Crossover Management, LLC | 3.7M | $260.8M | 6.3% | 4.2% | 0.0% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.5M | $246.2M | 0.0% | 3.9% | +12.0% |
| 10 | STATE STREET CORP | 3.4M | $244.2M | 0.0% | 3.9% | +29.9% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 3.3M | $235.7M | 0.0% | 3.8% | +9.3% |
| 12 | Foresite Capital Management VI LLC | 2.4M | $168.4M | 26.2% | 2.7% | +6.7% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $153.0M | 0.0% | 2.4% | +34.8% |
| 14 | Seven Fleet Capital Management LP | 1.9M | $134.0M | 22.1% | 2.1% | +2389.8% |
| 15 | EcoR1 Capital, LLC | 1.5M | $106.2M | 5.2% | 1.7% | +35.6% |
| 16 | DV Trading LLC | 1.4M | $102.3M | 3.4% | 1.6% | 0.0% |
| 17 | Avidity Partners Management LPNEW | 1.4M | $99.4M | 15.9% | 1.6% | new |
| 18 | ALLIANCEBERNSTEIN L.P. | 1.4M | $93.0M | 0.0% | 1.6% | +6.5% |
| 19 | FRANKLIN RESOURCES INC | 1.3M | $93.3M | 0.0% | 1.5% | -12.9% |
| 20 | MORGAN STANLEY | 1.2M | $83.6M | 0.0% | 1.3% | +126.3% |
| 21 | ACORN CAPITAL ADVISORS, LLC | 1.1M | $80.4M | 21.9% | 1.3% | +0.1% |
| 22 | Foresite Capital Management V, LLC | 1.1M | $76.7M | 21.2% | 1.2% | +7.5% |
| 23 | Logos Global Management LP | 1.0M | $71.0M | 3.1% | 1.1% | +73.9% |
| 24 | BANK OF AMERICA CORP /DE/ | 984,918 | $70.0M | 0.0% | 1.1% | -32.0% |
| 25 | UBS Group AG | 977,695 | $69.5M | 0.0% | 1.1% | -25.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.